AcelRx Pharmaceuticals Reports Publication of Manuscript Evaluating Sufentanil Sublingual Tablets for Moderate-to-Severe Acute Pain in the Emergency Department
Stock Information for AcelRx Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.